US Stock MarketDetailed Quotes

DCTH Delcath Systems

Watchlist
  • 5.440
  • +0.040+0.74%
Close May 2 16:00 ET
  • 5.440
  • 0.0000.00%
Post 16:00 ET
138.39MMarket Cap-1850P/E (TTM)

About Delcath Systems Company

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded in August 1988 and is headquartered in Queensbury, NY.

Company Profile

SymbolDCTH
Company NameDelcath Systems
Issue Price10.00
Founded1988
CEOMr. Gerard J. Michel
MarketNASDAQ
Employees76
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address566 Queensbury Avenue
CityQueensbury
ProvinceNew York
CountryUnited States of America
Zip Code12804
Phone1-212-489-2100
Websitehttp://www.delcath.com

Company Executives

  • Name
  • Position
  • Salary
  • Gerard J. Michel
  • Chief Executive Officer and Director
  • 2.52M
  • Dr. Vojislav Vukovic, M.D.,PhD
  • Chief Medical Officer
  • --
  • David L. Hoffman
  • General Counsel, Chief Compliance Officer and Corporate Secretary
  • --
  • Dr. Martha S. Rook, PhD
  • Chief Operating Officer
  • --
  • Kevin Muir
  • General Manager, Interventional Oncology
  • 1.02M
  • Sandra Pennell
  • Senior Vice President, Finance, Principal Financial Officer and Principal Accounting Officer
  • --
  • John Richard Sylvester
  • Non-Executive Chairman of the Board
  • 204.88K
  • Dr. Roger G. Stoll,PhD
  • Independent Director
  • 188.48K
  • Dr. Gilad Aharon
  • Independent Director
  • 172.96K
  • Elizabeth A. Czerepak
  • Independent Director
  • 188.51K
  • Steven Salamon
  • Independent Director
  • 113.12K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg